Skip to content

A randomized, controlled, double-blind clinical trial of esketamine injection for preventing hypotension during gastrointestinal surgery in elderly patients

A randomized, controlled, double-blind clinical trial of esketamine injection for preventing hypotension during gastrointestinal surgery in elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048716
Enrollment
Unknown
Registered
2021-07-13
Start date
2021-07-30
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension during gastrointestinal surgery in elderly patients

Interventions

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65 to 90 years, gender is not limited; 2. Patients who plan to undergo elective laparoscopic gastrointestinal surgery under general anesthesia, the expected duration of the surgery is more than 2 hours; 3. ASA score is I~III; 4. Voluntarily participate in this clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Preoperative visit blood pressure >=180/110 mm Hg (WHO-ISH hypertension guideline grade 3 hypertension); 2. Those with serious risk of increased intracranial pressure, such as intracranial tumor, intracranial infection, intracranial hemorrhage, etc.; 3. Severe liver and kidney dysfunction; 4. Those who have contraindications or allergies to experimental drugs and other anesthetic drugs; 5. Untreated or poorly controlled hyperthyroidism; 6. Patients with high intraocular pressure such as glaucoma; 7. Those who are taking reserpine; 8. Patients with severe impairment of auditory, visual and language system functions who cannot cooperate with the investigator's visit; 9. Confirmed/suspected of abuse or long-term use of narcotic sedative analgesics; Patients enrolled in other studies within 10.30 days.

Design outcomes

Primary

MeasureTime frame
The incidence of IOH(Intraoperative hypotension);

Secondary

MeasureTime frame
Cumulative time of IOH;Cumulative dose of vasopressors;The postoperative recovery quality of patients;Incidence of postoperative pain, nausea and vomiting;Postoperative outcomes of the patient;

Countries

China

Contacts

Public ContactWang Qiang

The First Affiliated Hospital of Xi'an Jiaotong University

dr.wangqiang@139.com+86 29 85323646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026